Nature
Acute lymphoblastic leukemia in patients treated with lenalidomide for multiple myeloma: a safety meta-analysis of randomized controlled trials combined with a retrospective study of the WHO’s pharmacovigilance database - Blood Cancer Journal
Dear Editor,Since the first Food and Drug Administration (FDA) approval of lenalidomide in treating patients with myelodysplastic syndromes (MDS) in 2005, its indications have been extended to lymphomas and multiple myeloma (MM).
6 days ago